Julie Engel
Director/Board Member at Yuma Regional Medical Center, Inc.
Profile
Julie Engel currently works at Yuma Regional Medical Center, Inc., as Director and Arizona-Mexico Commission, as Director from 2023.
Dr. Engel also formerly worked at Cytheris SA, as Vice President-Operations.
Julie Engel active positions
Companies | Position | Start |
---|---|---|
Yuma Regional Medical Center, Inc.
Yuma Regional Medical Center, Inc. Hospital/Nursing ManagementHealth Services Yuma Regional Medical Center, Inc. owns and operates hospitals. Its medical services include allergy, asthma and immunology, cancer care, imaging and radiology, eye care, clinical trials, rehabilitative services, surgery, orthopaedics, weight loss surgery and women’s health. The company was founded in 1958 and is headquartered in Yuma, AZ. | Director/Board Member | 2011-08-29 |
Arizona-Mexico Commission | Director/Board Member | 2023-08-17 |
Former positions of Julie Engel
Companies | Position | End |
---|---|---|
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Cytheris SA develops and manufactures drugs for immune modulation. It is a clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases. The firm's product CYT107 (glycosylated r-hIL-7), is in clinical development for two targeted indications with urgent medical needs and no current treatments: Progressive Multifocal Leukoencephalopathy (PML) in severely lymphopenic patients and Reduction of complications in Immune Non-Responders with HIV controlled by anti-retroviral treatment (HIV-INR). Cytheris has locations in France and The United States. The company was founded in January 1999 by Michel Morre and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Yuma Regional Medical Center, Inc.
Yuma Regional Medical Center, Inc. Hospital/Nursing ManagementHealth Services Yuma Regional Medical Center, Inc. owns and operates hospitals. Its medical services include allergy, asthma and immunology, cancer care, imaging and radiology, eye care, clinical trials, rehabilitative services, surgery, orthopaedics, weight loss surgery and women’s health. The company was founded in 1958 and is headquartered in Yuma, AZ. | Health Services |
Arizona-Mexico Commission |
- Stock Market
- Insiders
- Julie Engel